Parallel Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,982
| Closed | -$261K | – | 3716 |
|
|
2025
Q1 | $261K | Buy |
1,982
+27
| +1% | +$3.56K | 0.01% | 835 |
|
|
2024
Q4 | $163K | Buy |
1,955
+64
| +3% | +$5.35K | ﹤0.01% | 1018 |
|
|
2024
Q3 | $138K | Buy |
1,891
+277
| +17% | +$20.3K | ﹤0.01% | 1103 |
|
|
2024
Q2 | $111K | Buy |
1,614
+15
| +0.9% | +$1.03K | ﹤0.01% | 1133 |
|
|
2024
Q1 | $111K | Buy |
1,599
+35
| +2% | +$2.42K | ﹤0.01% | 1121 |
|
|
2023
Q4 | $112K | Buy |
1,564
+219
| +16% | +$15.7K | ﹤0.01% | 1069 |
|
|
2023
Q3 | $70.1K | Buy |
1,345
+113
| +9% | +$5.89K | ﹤0.01% | 1237 |
|
|
2023
Q2 | $78K | Hold |
1,232
| – | – | ﹤0.01% | 1188 |
|
|
2023
Q1 | $66.7K | Sell |
1,232
-1,272
| -51% | -$68.9K | ﹤0.01% | 1232 |
|
|
2022
Q4 | $133K | Sell |
2,504
-3
| -0.1% | -$159 | 0.01% | 876 |
|
|
2022
Q3 | $117K | Buy |
2,507
+3
| +0.1% | +$140 | 0.01% | 895 |
|
|
2022
Q2 | $143K | Sell |
2,504
-22
| -0.9% | -$1.26K | 0.01% | 824 |
|
|
2022
Q1 | $152K | Sell |
2,526
-118
| -4% | -$7.1K | 0.01% | 832 |
|
|
2021
Q4 | $138K | Sell |
2,644
-6
| -0.2% | -$313 | 0.01% | 883 |
|
|
2021
Q3 | $99K | Buy |
2,650
+150
| +6% | +$5.6K | ﹤0.01% | 977 |
|
|
2021
Q2 | $102K | Hold |
2,500
| – | – | ﹤0.01% | 932 |
|
|
2021
Q1 | $85K | Hold |
2,500
| – | – | ﹤0.01% | 945 |
|
|
2020
Q4 | $80K | Hold |
2,500
| – | – | ﹤0.01% | 887 |
|
|
2020
Q3 | $64K | Buy |
+2,500
| New | +$64K | ﹤0.01% | 953 |
|